A recent study highlights an increased risk of thromboembolic events in metastatic lung cancer patients treated with immune ...

A recent study found that the prevalence of thromboembolic events is increased in individuals with Dermatomyositis with ...

Other authors in 2006 [86] provided the rate of thromboembolic events among women who fulfilled obstetric APS criteria. About 16 of the 53 patients analyzed had previous thromboembolisms and only ...

Discover the heightened thromboembolic risk for metastatic lung cancer patients on immune checkpoint inhibitors. Learn about ...